⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for trastuzumab iv

Every month we try and update this database with for trastuzumab iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerNCT03674112
HER2-Positive E...
Pertuzumab and ...
Pertuzumab IV
Trastuzumab IV
18 Years - Hoffmann-La Roche
Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer PatientsNCT03144947
Cancer, Breast
Trastuzumab IV
Trastuzumab SC
Pertuzumab
Docetaxel
18 Years - Gruppo Oncologico Italiano di Ricerca Clinica
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast CancerNCT05415215
Early Breast Ca...
Locally Advance...
Inflammatory Br...
Fixed Dose Comb...
Pertuzumab IV
Trastuzumab IV
Trastuzumab Emt...
Investigator's ...
Surgery
Radiotherapy
18 Years - Hoffmann-La Roche
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerNCT03493854
Early Breast Ca...
Cyclophosphamid...
Doxorubicin
Docetaxel
Paclitaxel
Pertuzumab IV
FDC of Pertuzum...
Trastuzumab IV
Trastuzumab SC
Surgery
Post-operative ...
Hormone Therapy
18 Years - Hoffmann-La Roche
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerNCT03493854
Early Breast Ca...
Cyclophosphamid...
Doxorubicin
Docetaxel
Paclitaxel
Pertuzumab IV
FDC of Pertuzum...
Trastuzumab IV
Trastuzumab SC
Surgery
Post-operative ...
Hormone Therapy
18 Years - Hoffmann-La Roche
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast CancerNCT04024462
HER2-positive E...
Pertuzumab IV
Trastuzumab IV
Pertuzumab and ...
Doxorubicin
Cyclophosphamid...
Docetaxel
Surgery
Post-Operative ...
Hormone Therapy
18 Years - Hoffmann-La Roche
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: